Profil
Albert S.
Kildani is currently SVP-Investor Relations & Corporate Communications at ACADIA Pharmaceuticals, Inc. since 2023 and a Member of the National Investor Relations Institute.
Former positions include Senior Director-Investor Relations at Hologic, Inc. from 2012 to 2014; Senior Director-Investor Relations at Gen-Probe, Inc.; Director at SF Capital Group LLC from 2004 to 2009; Managing Director at Global Hunter Securities LLC from 2010 to 2011; VP-Investor Relations & Corporate Communications at Halozyme Therapeutics, Inc.; and VP-Investor Relations & Business Development at Vital Therapies, Inc. from 2014 to 2018.
Education includes undergraduate studies at Boston College.
Postes actifs de Albert Kildani
| Sociétés | Poste | Début |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Investor Relations Contact | 19/09/2023 |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
Anciens postes connus de Albert Kildani
| Sociétés | Poste | Fin |
|---|---|---|
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Investor Relations Contact | 01/09/2018 |
| HOLOGIC, INC. | Public Communications Contact | 01/08/2014 |
Global Hunter Securities LLC
Global Hunter Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/01/2011 |
SF Capital Group LLC
SF Capital Group LLC Investment ManagersFinance SF Capital invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides equity and debt financing for buyout transactions. | Directeur/Membre du Conseil | 01/01/2009 |
| HALOZYME THERAPEUTICS, INC. | Investor Relations Contact | - |
Formation de Albert Kildani
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Hologic, Inc.
Hologic, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and supplies diagnostics devices, medical imaging systems & surgical products for women's | Health Technology |
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis | Health Technology |
SF Capital Group LLC
SF Capital Group LLC Investment ManagersFinance SF Capital invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides equity and debt financing for buyout transactions. | Finance |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Hunter Securities LLC
Global Hunter Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
















